BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ibarra LE, Camorani S, Agnello L, Pedone E, Pirone L, Chesta CA, Palacios RE, Fedele M, Cerchia L. Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles. Pharmaceutics 2022;14:626. [DOI: 10.3390/pharmaceutics14030626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Razlansari M, Jafarinejad S, rahdar A, Shirvaliloo M, Arshad R, Fathi-karkan S, Mirinejad S, Sargazi S, Sheervalilou R, Ajalli N, Pandey S. Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer. Mol Cell Biochem 2022. [DOI: 10.1007/s11010-022-04614-x] [Reference Citation Analysis]
2 Gholikhani T, Kumar S, Valizadeh H, Mahdinloo S, Adibkia K, Zakeri-milani P, Barzegar-jalali M, Jimenez B. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics. IJMS 2022;23:14475. [DOI: 10.3390/ijms232214475] [Reference Citation Analysis]
3 Huang K, Yan M, Zhang H, Xue J, Chen J. A phthalocyanine-based photosensitizer for effectively combating triple negative breast cancer with enhanced photodynamic anticancer activity and immune response. Eur J Med Chem 2022;241:114644. [PMID: 35939997 DOI: 10.1016/j.ejmech.2022.114644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Camorani S, Tortorella S, Agnello L, Spanu C, d’Argenio A, Nilo R, Zannetti A, Locatelli E, Fedele M, Comes Franchini M, Cerchia L. Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells. Pharmaceutics 2022;14:2225. [DOI: 10.3390/pharmaceutics14102225] [Reference Citation Analysis]
5 Camorani S, d'Argenio A, Agnello L, Nilo R, Zannetti A, Ibarra LE, Fedele M, Cerchia L. Optimization of Short RNA Aptamers for TNBC Cell Targeting. Int J Mol Sci 2022;23:3511. [PMID: 35408872 DOI: 10.3390/ijms23073511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Spanu C, Camorani S, Tortorella S, Agnello L, Maturi M, Comes Franchini M, Cerchia L, Locatelli E. Synthesis and functionalization of casein nanoparticles with aptamers for triple-negative breast cancer targeting. New J Chem 2022. [DOI: 10.1039/d2nj03367d] [Reference Citation Analysis]